Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection
Joshua J. Meeks, Peter C. Black, Matthew Galsky, Petros Grivas, Noah M. Hahn, Syed A. Hussain, Matthew I. Milowsky, Gary D. Steinberg, Robert S. Svatek, Jonathan E. Rosenberg
Profundice en los temas de investigación de 'Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection'. En conjunto forman una huella única.